Cargando…

Bioreactor Technologies for Enhanced Organoid Culture

An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Licata, Joseph P., Schwab, Kyle H., Har-el, Yah-el, Gerstenhaber, Jonathan A., Lelkes, Peter I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380004/
https://www.ncbi.nlm.nih.gov/pubmed/37511186
http://dx.doi.org/10.3390/ijms241411427
_version_ 1785080103701577728
author Licata, Joseph P.
Schwab, Kyle H.
Har-el, Yah-el
Gerstenhaber, Jonathan A.
Lelkes, Peter I.
author_facet Licata, Joseph P.
Schwab, Kyle H.
Har-el, Yah-el
Gerstenhaber, Jonathan A.
Lelkes, Peter I.
author_sort Licata, Joseph P.
collection PubMed
description An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the successful culture of organoids in vitro differ significantly from those of traditional monolayer cell cultures. The generation and maturation of high-fidelity organoids entails developing and optimizing environmental conditions to provide the optimal cues for growth and 3D maturation, such as oxygenation, mechanical and fluidic activation, nutrition gradients, etc. To this end, we discuss the four main categories of bioreactors used for organoid culture: stirred bioreactors (SBR), microfluidic bioreactors (MFB), rotating wall vessels (RWV), and electrically stimulating (ES) bioreactors. We aim to lay out the state-of-the-art of both commercial and in-house developed bioreactor systems, their benefits to the culture of organoids derived from various cells and tissues, and the limitations of bioreactor technology, including sterilization, accessibility, and suitability and ease of use for long-term culture. Finally, we discuss future directions for improvements to existing bioreactor technology and how they may be used to enhance organoid culture for specific applications.
format Online
Article
Text
id pubmed-10380004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103800042023-07-29 Bioreactor Technologies for Enhanced Organoid Culture Licata, Joseph P. Schwab, Kyle H. Har-el, Yah-el Gerstenhaber, Jonathan A. Lelkes, Peter I. Int J Mol Sci Review An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the successful culture of organoids in vitro differ significantly from those of traditional monolayer cell cultures. The generation and maturation of high-fidelity organoids entails developing and optimizing environmental conditions to provide the optimal cues for growth and 3D maturation, such as oxygenation, mechanical and fluidic activation, nutrition gradients, etc. To this end, we discuss the four main categories of bioreactors used for organoid culture: stirred bioreactors (SBR), microfluidic bioreactors (MFB), rotating wall vessels (RWV), and electrically stimulating (ES) bioreactors. We aim to lay out the state-of-the-art of both commercial and in-house developed bioreactor systems, their benefits to the culture of organoids derived from various cells and tissues, and the limitations of bioreactor technology, including sterilization, accessibility, and suitability and ease of use for long-term culture. Finally, we discuss future directions for improvements to existing bioreactor technology and how they may be used to enhance organoid culture for specific applications. MDPI 2023-07-13 /pmc/articles/PMC10380004/ /pubmed/37511186 http://dx.doi.org/10.3390/ijms241411427 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Licata, Joseph P.
Schwab, Kyle H.
Har-el, Yah-el
Gerstenhaber, Jonathan A.
Lelkes, Peter I.
Bioreactor Technologies for Enhanced Organoid Culture
title Bioreactor Technologies for Enhanced Organoid Culture
title_full Bioreactor Technologies for Enhanced Organoid Culture
title_fullStr Bioreactor Technologies for Enhanced Organoid Culture
title_full_unstemmed Bioreactor Technologies for Enhanced Organoid Culture
title_short Bioreactor Technologies for Enhanced Organoid Culture
title_sort bioreactor technologies for enhanced organoid culture
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380004/
https://www.ncbi.nlm.nih.gov/pubmed/37511186
http://dx.doi.org/10.3390/ijms241411427
work_keys_str_mv AT licatajosephp bioreactortechnologiesforenhancedorganoidculture
AT schwabkyleh bioreactortechnologiesforenhancedorganoidculture
AT harelyahel bioreactortechnologiesforenhancedorganoidculture
AT gerstenhaberjonathana bioreactortechnologiesforenhancedorganoidculture
AT lelkespeteri bioreactortechnologiesforenhancedorganoidculture